| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
CG Oncology, Inc.
13G/A
CGON · 156944100
|
4.9% |
8/14/2026
Event 6/30/2026
|
||||
| Foresite Capital Fund V, L.P. | 1.2% | |||||
| Foresite Capital Management V, LLC | 1.2% | |||||
| Foresite Capital Opportunity Fund V, L.P. | 1.0% | |||||
| Foresite Capital Opportunity Management V, LLC | 1.0% | |||||
| Foresite Capital Fund VI LP | 2.7% | |||||
| Foresite Capital Management VI LLC | 2.7% | |||||
| James B. Tananbaum | 4.9% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.